Eetu Heervä
eaheer@utu.fi |
Expertese
- Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study (2021)
- Lancet regional health - Europe
- Signaling pathways in human osteoclasts differentiation: ERK1/2 as a key player (2021)
- Molecular Biology Reports
- An easily adaptable validated risk score predicts cancer-specific survival in stage II colon cancer (2020)
- Acta Oncologica
- Overall Survival and Metastasis Resections in Patients with Metastatic Colorectal Cancer Using Electorinic Medical Records (2018)
- Journal of Gastrointestinal Surgery
- Trends in presentation, treatment and survival of 1777 patients with colorectal cancer over a decade: a Biobank study (2018)
- Acta Oncologica
- Follow-Up of Six Patients with Neurofibromatosis 1-Related Osteoporosis Treated with Alendronate for 23 Months (2014)
- Calcified Tissue International
- A Controlled Register-Based Study of 460 Neurofibromatosis 1 Patients: Increased Fracture Risk in Children and Adults Over 41 Years of Age (2012)
- Journal of Bone and Mineral Research
- Osteoclasts derived from patients with neurofibromatosis 1 (NF1) display insensitivity to bisphosphonates in vitro (2012)
- BONE
- Osteoclasts of Patients with Neurofibromatosis 1 (NF 1) (2012) Osteoclasts: Morphology, Functions and Clinical Implications Heervä E, Peltonen J
- Short mandible, maxilla and cranial base are common in patients with neurofibromatosis 1 (2011)
- European Journal of Oral Sciences
- Osteoclasts in neurofibromatosis type 1 display enhanced resorption capacity, aberrant morphology, and resistance to serum deprivation (2010)
- BONE